{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T17:28:15Z","timestamp":1732037295266},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,2,11]],"date-time":"2018-02-11T00:00:00Z","timestamp":1518307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00424-018-2117-0","type":"journal-article","created":{"date-parts":[[2018,2,11]],"date-time":"2018-02-11T06:43:58Z","timestamp":1518331438000},"page":"867-881","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development of obesity can be prevented in rats by chronic icv infusions of AngII but less by Ang(1\u20137)"],"prefix":"10.1007","volume":"470","author":[{"given":"Martina","family":"Winkler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"St\u00f6lting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Binder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Raasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,11]]},"reference":[{"key":"2117_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.peptides.2014.07.023","volume":"60","author":"JM Andrade","year":"2014","unstructured":"Andrade JM, Lemos FO, da Fonseca PS, Millan RD, de Sousa FB, Guimaraes AL, Qureshi M, Feltenberger JD, de Paula AM, Neto JT, Lopes MT, Andrade HM, Santos RA, Santos SH (2014) Proteomic white adipose tissue analysis of obese mice fed with a high-fat diet and treated with oral angiotensin-(1-7). Peptides 60:56\u201362. \n                    https:\/\/doi.org\/10.1016\/j.peptides.2014.07.023","journal-title":"Peptides"},{"issue":"2","key":"2117_CR2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1161\/01.HYP.37.2.408","volume":"37","author":"O Baltatu","year":"2001","unstructured":"Baltatu O, Janssen BJ, Bricca G, Plehm R, Monti J, Ganten D, Bader M (2001) Alterations in blood pressure and heart rate variability in transgenic rats with low brain angiotensinogen. Hypertension 37(2):408\u2013413. \n                    https:\/\/doi.org\/10.1161\/01.HYP.37.2.408","journal-title":"Hypertension"},{"key":"2117_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000264398","volume":"63","author":"WA Banks","year":"2010","unstructured":"Banks WA (2010) Blood-brain barrier as a regulatory interface. Forum Nutr 63:102\u2013110","journal-title":"Forum Nutr"},{"issue":"5","key":"2117_CR4","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2337\/diabetes.53.5.1253","volume":"53","author":"WA Banks","year":"2004","unstructured":"Banks WA, Coon AB, Robinson SM, Moinuddin A, Shultz JM, Nakaoke R, Morley JE (2004) Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes 53(5):1253\u20131260. \n                    https:\/\/doi.org\/10.2337\/diabetes.53.5.1253","journal-title":"Diabetes"},{"issue":"11","key":"2117_CR5","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1172\/JCI118698","volume":"97","author":"M Brink","year":"1996","unstructured":"Brink M, Wellen J, Delafontaine P (1996) Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J Clin Invest 97(11):2509\u20132516. \n                    https:\/\/doi.org\/10.1172\/JCI118698","journal-title":"J Clin Invest"},{"issue":"1","key":"2117_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1677\/jme.0.0290023","volume":"29","author":"SA Bustin","year":"2002","unstructured":"Bustin SA (2002) Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 29(1):23\u201339. \n                    https:\/\/doi.org\/10.1677\/jme.0.0290023","journal-title":"J Mol Endocrinol"},{"issue":"5","key":"2117_CR7","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1210\/jc.2004-1995","volume":"90","author":"A Cabassi","year":"2005","unstructured":"Cabassi A, Coghi P, Govoni P, Barouhiel E, Speroni E, Cavazzini S, Cantoni AM, Scandroglio R, Fiaccadori E (2005) Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat. J Clin Endocrinol Metab 90(5):2888\u20132897. \n                    https:\/\/doi.org\/10.1210\/jc.2004-1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"9-10","key":"2117_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s00335-014-9538-7","volume":"25","author":"J Cantley","year":"2014","unstructured":"Cantley J (2014) The control of insulin secretion by adipokines: current evidence for adipocyte-beta cell endocrine signalling in metabolic homeostasis. Mamm Genome 25(9-10):442\u2013454. \n                    https:\/\/doi.org\/10.1007\/s00335-014-9538-7","journal-title":"Mamm Genome"},{"issue":"4","key":"2117_CR9","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1172\/JCI88641","volume":"127","author":"KE Claflin","year":"2017","unstructured":"Claflin KE, Sandgren JA, Lambertz AM, Weidemann BJ, Littlejohn NK, Burnett CM, Pearson NA, Morgan DA, Gibson-Corley KN, Rahmouni K, Grobe JL (2017) Angiotensin AT1A receptors on leptin receptor-expressing cells control resting metabolism. J Clin Invest 127(4):1414\u20131424. \n                    https:\/\/doi.org\/10.1172\/JCI88641","journal-title":"J Clin Invest"},{"issue":"6","key":"2117_CR10","doi-asserted-by":"publisher","first-page":"E1081","DOI":"10.1152\/ajpendo.00307.2011","volume":"301","author":"AD Kloet de","year":"2011","unstructured":"de Kloet AD, Krause EG, Scott KA, Foster MT, Herman JP, Sakai RR, Seeley RJ, Woods SC (2011) Central angiotensin II has catabolic action at white and brown adipose tissue. Am J Physiol Endocrinol Metab 301(6):E1081\u2013E1091. \n                    https:\/\/doi.org\/10.1152\/ajpendo.00307.2011","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"2117_CR11","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1523\/JNEUROSCI.3806-12.2013","volume":"33","author":"AD Kloet de","year":"2013","unstructured":"de Kloet AD, Pati D, Wang L, Hiller H, Sumners C, Frazier CJ, Seeley RJ, Herman JP, Woods SC, Krause EG (2013) Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus protect against diet-induced obesity. J Neurosci 33(11):4825\u20134833. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3806-12.2013","journal-title":"J Neurosci"},{"key":"2117_CR12","first-page":"R498","volume":"242","author":"NR Di","year":"1982","unstructured":"Di NR, Mendelsohn FA, Hutchinson JS, Takata Y, Doyle AE (1982) Dissociation of dipsogenic and pressor responses to chronic central angiotensin II in rats. Am J Phys 242:R498\u2013R504","journal-title":"Am J Phys"},{"issue":"11","key":"2117_CR13","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1113\/EP086417","volume":"102","author":"RC Dos-Santos","year":"2017","unstructured":"Dos-Santos RC, Monteiro L, Paes-Leme B, Lustrino D, Antunes-Rodrigues J, Mecawi AS, Reis LC (2017) Central angiotensin-(1-7) increases osmotic thirst. Exp Physiol 102(11):1397\u20131404. \n                    https:\/\/doi.org\/10.1113\/EP086417","journal-title":"Exp Physiol"},{"issue":"6","key":"2117_CR14","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1161\/01.HYP.35.6.1270","volume":"35","author":"S Engeli","year":"2000","unstructured":"Engeli S, Negrel R, Sharma AM (2000) Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 35(6):1270\u20131277. \n                    https:\/\/doi.org\/10.1161\/01.HYP.35.6.1270","journal-title":"Hypertension"},{"issue":"2","key":"2117_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1161\/CIRCRESAHA.109.208645","volume":"106","author":"Y Feng","year":"2010","unstructured":"Feng Y, Xia H, Cai Y, Halabi CM, Becker LK, Santos RA, Speth RC, Sigmund CD, Lazartigues E (2010) Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension. Circ Res 106(2):373\u2013382. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.208645","journal-title":"Circ Res"},{"issue":"3","key":"2117_CR16","doi-asserted-by":"publisher","first-page":"H393","DOI":"10.1152\/ajpheart.00075.2012","volume":"303","author":"PS Guimaraes","year":"2012","unstructured":"Guimaraes PS, Santiago NM, Xavier CH, Velloso EP, Fontes MA, Santos RA, Campagnole-Santos MJ (2012) Chronic infusion of angiotensin-(1-7) into the lateral ventricle of the brain attenuates hypertension in DOCA-salt rats. Am J Physiol Heart Circ Physiol 303(3):H393\u2013H400. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00075.2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"Pt A","key":"2117_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.phrs.2017.06.016","volume":"125","author":"G Huber","year":"2017","unstructured":"Huber G, Schuster F, Raasch W (2017) Brain renin-angiotensin system in the pathophysiology of cardiovascular diseases. Pharmacol Res 125(Pt A):72\u201390. \n                    https:\/\/doi.org\/10.1016\/j.phrs.2017.06.016","journal-title":"Pharmacol Res"},{"issue":"1","key":"2117_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1046\/j.1365-2826.1998.00182.x","volume":"10","author":"D Jezova","year":"1998","unstructured":"Jezova D, Ochedalski T, Kiss A, Brain AG (1998) Angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress. J Neuroendocrinol 10(1):67\u201372","journal-title":"J Neuroendocrinol"},{"issue":"3","key":"2117_CR19","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1113\/expphysiol.2014.084095","volume":"100","author":"T Kadoguchi","year":"2015","unstructured":"Kadoguchi T, Kinugawa S, Takada S, Fukushima A, Furihata T, Homma T, Masaki Y, Mizushima W, Nishikawa M, Takahashi M, Yokota T, Matsushima S, Okita K, Tsutsui H (2015) Angiotensin II can directly induce mitochondrial dysfunction, decrease oxidative fibre number and induce atrophy in mouse hindlimb skeletal muscle. Exp Physiol 100(3):312\u2013322. \n                    https:\/\/doi.org\/10.1113\/expphysiol.2014.084095","journal-title":"Exp Physiol"},{"key":"2117_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neuropharm.2015.04.036","volume":"97","author":"LM Kangussu","year":"2015","unstructured":"Kangussu LM, Guimaraes PS, Nadu AP, Melo MB, Santos RA, Campagnole-Santos MJ (2015) Activation of angiotensin-(1-7)\/Mas axis in the brain lowers blood pressure and attenuates cardiac remodeling in hypertensive transgenic (mRen2)27 rats. Neuropharmacology 97:58\u201366. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2015.04.036","journal-title":"Neuropharmacology"},{"issue":"3","key":"2117_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1152\/physiolgenomics.00163.2005","volume":"23","author":"SO Kasper","year":"2005","unstructured":"Kasper SO, Carter CS, Ferrario CM, Ganten D, Ferder LF, Sonntag WE, Gallagher PE, Diz DI (2005) Growth, metabolism, and blood pressure disturbances during aging in transgenic rats with altered brain renin-angiotensin systems. Physiol Genomics 23(3):311\u2013317. \n                    https:\/\/doi.org\/10.1152\/physiolgenomics.00163.2005","journal-title":"Physiol Genomics"},{"key":"2117_CR22","doi-asserted-by":"publisher","unstructured":"King VL, English VL, Bharadwaj K, Cassis LA (2013) Angiotensin II stimulates sympathetic neurotransmission to adipose tissue. Physiol Rep 1(2): \n                    https:\/\/doi.org\/10.1002\/phy2.14","DOI":"10.1002\/phy2.14"},{"issue":"10-11","key":"2117_CR23","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/j.1440-1681.1996.tb01137.x","volume":"23","author":"CN May","year":"1996","unstructured":"May CN (1996) Prolonged systemic and regional haemodynamic effects of intracerebroventricular angiotensin II in conscious sheep. Clin Exp Pharmacol Physiol 23(10-11):878\u2013884. \n                    https:\/\/doi.org\/10.1111\/j.1440-1681.1996.tb01137.x","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"2117_CR24","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/ki.1994.424","volume":"46","author":"MJ McKinley","year":"1994","unstructured":"McKinley MJ, Evered M, Mathai M, Coghlan JP (1994) Effects of central losartan on plasma renin and centrally mediated natriuresis. Kidney Int 46(6):1479\u20131482. \n                    https:\/\/doi.org\/10.1038\/ki.1994.424","journal-title":"Kidney Int"},{"issue":"6","key":"2117_CR25","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1161\/01.HYP.37.6.1375","volume":"37","author":"MJ McKinley","year":"2001","unstructured":"McKinley MJ, McBurnie MI, Mathai ML (2001) Neural mechanisms subserving central angiotensinergic influences on plasma renin in sheep. Hypertension 37(6):1375\u20131381. \n                    https:\/\/doi.org\/10.1161\/01.HYP.37.6.1375","journal-title":"Hypertension"},{"issue":"1","key":"2117_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0014-5793(94)01292-9","volume":"357","author":"R Metzger","year":"1995","unstructured":"Metzger R, Bader M, Ludwig T, Berberich C, Bunnemann B, Ganten D (1995) Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues. FEBS Lett 357(1):27\u201332. \n                    https:\/\/doi.org\/10.1016\/0014-5793(94)01292-9","journal-title":"FEBS Lett"},{"issue":"2","key":"2117_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000278748","volume":"56","author":"A Miesel","year":"2010","unstructured":"Miesel A, M\u00fcller H, Thermann M, Heidbreder M, Dominiak P, Raasch W (2010) Overfeeding-induced obesity in spontaneously hypertensive rats: an animal model of the human metabolic syndrome. Ann Nutr Metab 56(2):127\u2013142. \n                    https:\/\/doi.org\/10.1159\/000278748","journal-title":"Ann Nutr Metab"},{"issue":"3","key":"2117_CR28","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/bph.12510","volume":"171","author":"H M\u00fcller-Fielitz","year":"2014","unstructured":"M\u00fcller-Fielitz H, H\u00fcbel N, Mildner M, Vogt FM, Barkhausen J, Raasch W (2014) Chronic blockade of angiotensin AT(1) receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats. Br J Pharmacol 171(3):746\u2013760. \n                    https:\/\/doi.org\/10.1111\/bph.12510","journal-title":"Br J Pharmacol"},{"issue":"3","key":"2117_CR29","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1210\/en.2011-0183","volume":"153","author":"H M\u00fcller-Fielitz","year":"2012","unstructured":"M\u00fcller-Fielitz H, Landolt J, Heidbreder M, Werth S, Vogt FM, J\u00f6hren O, Raasch W (2012) Improved insulin sensitivity after long-term treatment with AT1 blockers is not associated with PPARgamma target gene regulation. Endocrinology 153(3):1103\u20131115. \n                    https:\/\/doi.org\/10.1210\/en.2011-0183","journal-title":"Endocrinology"},{"issue":"3","key":"2117_CR30","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/bph.12949","volume":"172","author":"H M\u00fcller-Fielitz","year":"2015","unstructured":"M\u00fcller-Fielitz H, Lau M, Geissler C, Werner L, Winkler M, Raasch W (2015) Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats. Br J Pharmacol 172(3):857\u2013868. \n                    https:\/\/doi.org\/10.1111\/bph.12949","journal-title":"Br J Pharmacol"},{"issue":"8","key":"2117_CR31","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1111\/j.1476-5381.2012.01953.x","volume":"166","author":"H M\u00fcller-Fielitz","year":"2012","unstructured":"M\u00fcller-Fielitz H, Lau M, J\u00f6hren O, Stellmacher F, Schwaninger M, Raasch W (2012) Blood pressure response to angiotensin II is enhanced in obese Zucker rats and is attributed to an aldosterone-dependent mechanism. Br J Pharmacol 166(8):2417\u20132429. \n                    https:\/\/doi.org\/10.1111\/j.1476-5381.2012.01953.x","journal-title":"Br J Pharmacol"},{"issue":"2","key":"2117_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1055\/s-0032-1327679","volume":"45","author":"H M\u00fcller-Fielitz","year":"2013","unstructured":"M\u00fcller-Fielitz H, Raasch W (2013) Angiotensin II impairs glucose utilization in obese Zucker rats by increasing HPA activity via an adrenal-dependent mechanism. Horm Metab Res 45(2):173\u2013180. \n                    https:\/\/doi.org\/10.1055\/s-0032-1327679","journal-title":"Horm Metab Res"},{"issue":"1","key":"2117_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1677\/JOE-09-0363","volume":"204","author":"H M\u00fcller","year":"2010","unstructured":"M\u00fcller H, Kroger J, J\u00f6hren O, Szymczak S, Bader M, Dominiak P, Raasch W (2010) Stress sensitivity is increased in transgenic rats with low brain angiotensinogen. J Endocrinol 204(1):85\u201392. \n                    https:\/\/doi.org\/10.1677\/JOE-09-0363","journal-title":"J Endocrinol"},{"issue":"3","key":"2117_CR34","doi-asserted-by":"publisher","first-page":"E802","DOI":"10.1152\/ajpendo.00650.2006","volume":"293","author":"H M\u00fcller","year":"2007","unstructured":"M\u00fcller H, Schweitzer N, J\u00f6hren O, Dominiak P, Raasch W (2007) Angiotensin II stimulates the reactivity of the pituitary-adrenal axis in leptin-resistant Zucker rats, thereby influencing the glucose utilization. Am J Physiol Endocrinol Metab 293(3):E802\u2013E810. \n                    https:\/\/doi.org\/10.1152\/ajpendo.00650.2006","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"2117_CR35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/joim.12649","volume":"282","author":"K Nakamura","year":"2017","unstructured":"Nakamura K, Velho G, Bouby N (2017) Vasopressin and metabolic disorders: translation from experimental models to clinical use. J Intern Med 282(4):298\u2013309. \n                    https:\/\/doi.org\/10.1111\/joim.12649","journal-title":"J Intern Med"},{"issue":"5","key":"2117_CR36","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1161\/HYPERTENSIONAHA.112.196782","volume":"60","author":"M Nautiyal","year":"2012","unstructured":"Nautiyal M, Shaltout HA, de Lima DC, do NK, Chappell MC, Diz DI (2012) Central angiotensin-(1-7) improves vagal function independent of blood pressure in hypertensive (mRen2)27 rats. Hypertension 60(5):1257\u20131265. \n                    https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.196782","journal-title":"Hypertension"},{"key":"2117_CR37","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.peptides.2014.03.006","volume":"55","author":"JM Oliveira Andrade","year":"2014","unstructured":"Oliveira Andrade JM, Paraiso AF, Garcia ZM, Ferreira AV, Sinisterra RD, Sousa FB, Guimaraes AL, de Paula AM, Campagnole-Santos MJ, dos Santos RA, Santos SH (2014) Cross talk between angiotensin-(1-7)\/Mas axis and sirtuins in adipose tissue and metabolism of high-fat feed mice. Peptides 55:158\u2013165. \n                    https:\/\/doi.org\/10.1016\/j.peptides.2014.03.006","journal-title":"Peptides"},{"key":"2117_CR38","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"GWC Paxinos","year":"1998","unstructured":"Paxinos GWC (1998) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego"},{"issue":"1","key":"2117_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0006-8993(02)03676-4","volume":"959","author":"JP Porter","year":"2003","unstructured":"Porter JP, Anderson JM, Robison RJ, Phillips AC (2003) Effect of central angiotensin II on body weight gain in young rats. Brain Res 959(1):20\u201328. \n                    https:\/\/doi.org\/10.1016\/S0006-8993(02)03676-4","journal-title":"Brain Res"},{"issue":"12","key":"2117_CR40","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1097\/00004872-200212000-00030","volume":"20","author":"W Raasch","year":"2002","unstructured":"Raasch W, Bartels T, Schwartz C, H\u00e4user W, R\u00fctten H, Dominiak P (2002) Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors? J Hypertens 20(12):2495\u20132504. \n                    https:\/\/doi.org\/10.1097\/00004872-200212000-00030","journal-title":"J Hypertens"},{"issue":"3","key":"2117_CR41","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/01.HYP.0000138406.13413.0e","volume":"44","author":"W Raasch","year":"2004","unstructured":"Raasch W, Dominiak P, Ziegler A, Dendorfer A (2004) Reduction of vascular noradrenaline sensitivity by AT1 antagonists depends on functional sympathetic innervation. Hypertension 44(3):346\u2013351. \n                    https:\/\/doi.org\/10.1161\/01.HYP.0000138406.13413.0e","journal-title":"Hypertension"},{"issue":"2","key":"2117_CR42","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2337\/db07-0953","volume":"57","author":"SH Santos","year":"2008","unstructured":"Santos SH, Fernandes LR, Mario EG, Ferreira AV, Porto LC, Alvarez-Leite JI, Botion LM, Bader M, Alenina N, Santos RA (2008) Mas deficiency in FVB\/N mice produces marked changes in lipid and glycemic metabolism. Diabetes 57(2):340\u2013347. \n                    https:\/\/doi.org\/10.2337\/db07-0953","journal-title":"Diabetes"},{"issue":"7","key":"2117_CR43","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1073\/pnas.96.7.3975","volume":"96","author":"M Schinke","year":"1999","unstructured":"Schinke M, Baltatu O, Bohm M, Peters J, Rascher W, Bricca G, Lippoldt A, Ganten D, Bader M (1999) Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc Natl Acad Sci U S A 96(7):3975\u20133980. \n                    https:\/\/doi.org\/10.1073\/pnas.96.7.3975","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"2117_CR44","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1111\/bph.13172","volume":"172","author":"J Schuchard","year":"2015","unstructured":"Schuchard J, Winkler M, Stolting I, Schuster F, Vogt FM, Barkhausen J, Thorns C, Santos RA, Bader M, Raasch W (2015) Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)\/Mas-dependent pathway. Br J Pharmacol 172(15):3764\u20133778. \n                    https:\/\/doi.org\/10.1111\/bph.13172","journal-title":"Br J Pharmacol"},{"issue":"2","key":"2117_CR45","doi-asserted-by":"publisher","first-page":"E237","DOI":"10.1152\/ajpendo.00408.2009","volume":"298","author":"C Schulz","year":"2010","unstructured":"Schulz C, Paulus K, Lobmann R, Dallman M, Lehnert H (2010) Endogenous ACTH, not only alpha-melanocyte-stimulating hormone, reduces food intake mediated by hypothalamic mechanisms. Am J Physiol Endocrinol Metab 298(2):E237\u2013E244. \n                    https:\/\/doi.org\/10.1152\/ajpendo.00408.2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6778","key":"2117_CR46","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/35007534","volume":"404","author":"MW Schwartz","year":"2000","unstructured":"Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404(6778):661\u2013671. \n                    https:\/\/doi.org\/10.1038\/35007534","journal-title":"Nature"},{"issue":"3","key":"2117_CR47","doi-asserted-by":"publisher","first-page":"R313","DOI":"10.1152\/ajpregu.00575.2011","volume":"302","author":"CD Sigmund","year":"2012","unstructured":"Sigmund CD (2012) Divergent mechanism regulating fluid intake and metabolism by the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 302(3):R313\u2013R320. \n                    https:\/\/doi.org\/10.1152\/ajpregu.00575.2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"2117_CR48","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/oby.2005.113","volume":"13","author":"T Skurk","year":"2005","unstructured":"Skurk T, van Harmelen V, Blum WF, Hauner H (2005) Angiotensin II promotes leptin production in cultured human fat cells by an ERK1\/2-dependent pathway. Obes Res 13(6):969\u2013973. \n                    https:\/\/doi.org\/10.1038\/oby.2005.113","journal-title":"Obes Res"},{"issue":"2","key":"2117_CR49","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1172\/JCI22324","volume":"115","author":"YH Song","year":"2005","unstructured":"Song YH, Li Y, Du J, Mitch WE, Rosenthal N, Delafontaine P (2005) Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest 115(2):451\u2013458. \n                    https:\/\/doi.org\/10.1172\/JCI22324","journal-title":"J Clin Invest"},{"issue":"1","key":"2117_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/2044-5040-4-20","volume":"4","author":"AM Tabony","year":"2014","unstructured":"Tabony AM, Yoshida T, Sukhanov S, Delafontaine P (2014) Protein phosphatase 2C-alpha knockdown reduces angiotensin II-mediated skeletal muscle wasting via restoration of mitochondrial recycling and function. Skelet Muscle 4(1):20. \n                    https:\/\/doi.org\/10.1186\/2044-5040-4-20","journal-title":"Skelet Muscle"},{"issue":"2","key":"2117_CR51","doi-asserted-by":"publisher","first-page":"H182","DOI":"10.1152\/ajpheart.00518.2013","volume":"307","author":"YK Wang","year":"2014","unstructured":"Wang YK, Shen D, Hao Q, Yu Q, Wu ZT, Deng Y, Chen YF, Yuan WJ, Hu QK, Su DF, Wang WZ (2014) Overexpression of angiotensin-converting enzyme 2 attenuates tonically active glutamatergic input to the rostral ventrolateral medulla in hypertensive rats. Am J Physiol Heart Circ Physiol 307(2):H182\u2013H190. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00518.2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"2117_CR52","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/bph.13461","volume":"173","author":"M Winkler","year":"2016","unstructured":"Winkler M, Schuchard J, Stolting I, Vogt FM, Barkhausen J, Thorns C, Bader M, Raasch W (2016) The brain renin-angiotensin system plays a crucial role in regulating body weight in diet-induced obesity in rats. Br J Pharmacol 173(10):1602\u20131617. \n                    https:\/\/doi.org\/10.1111\/bph.13461","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2117_CR53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00424-012-1102-2","volume":"465","author":"JW Wright","year":"2013","unstructured":"Wright JW, Harding JW (2013) The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases. Pflugers Arch 465(1):133\u2013151. \n                    https:\/\/doi.org\/10.1007\/s00424-012-1102-2","journal-title":"Pflugers Arch"},{"key":"2117_CR54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejphar.2014.12.007","volume":"748","author":"J Wu","year":"2015","unstructured":"Wu J, Zhao D, Wu S, Wang D (2015) Ang-(1-7) exerts protective role in blood-brain barrier damage by the balance of TIMP-1\/MMP-9. Eur J Pharmacol 748:30\u201336. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2014.12.007","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"2117_CR55","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1161\/CIRCRESAHA.113.301811","volume":"113","author":"H Xia","year":"2013","unstructured":"Xia H, Sriramula S, Chhabra KH, Lazartigues E (2013) Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension. Circ Res 113(9):1087\u20131096. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.301811","journal-title":"Circ Res"},{"issue":"6","key":"2117_CR56","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1161\/HYPERTENSIONAHA.111.176636","volume":"58","author":"L Xiao","year":"2011","unstructured":"Xiao L, Gao L, Lazartigues E, Zucker IH (2011) Brain-selective overexpression of angiotensin-converting enzyme 2 attenuates sympathetic nerve activity and enhances baroreflex function in chronic heart failure. Hypertension 58(6):1057\u20131065. \n                    https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.176636","journal-title":"Hypertension"},{"issue":"4","key":"2117_CR57","doi-asserted-by":"publisher","first-page":"R804","DOI":"10.1152\/ajpregu.00222.2010","volume":"300","author":"P Xu","year":"2011","unstructured":"Xu P, Sriramula S, Lazartigues E (2011) ACE2\/ANG-(1-7)\/Mas pathway in the brain: the axis of good. Am J Physiol Regul Integr Comp Physiol 300(4):R804\u2013R817. \n                    https:\/\/doi.org\/10.1152\/ajpregu.00222.2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"4","key":"2117_CR58","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/1470320311412809","volume":"12","author":"M Yamazato","year":"2011","unstructured":"Yamazato M, Ferreira AJ, Yamazato Y, Diez-Freire C, Yuan L, Gillies R, Raizada MK (2011) Gene transfer of angiotensin-converting enzyme 2 in the nucleus tractus solitarius improves baroreceptor heart rate reflex in spontaneously hypertensive rats. J Renin-Angiotensin-Aldosterone Syst 12(4):456\u2013461. \n                    https:\/\/doi.org\/10.1177\/1470320311412809","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"issue":"4","key":"2117_CR59","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1161\/01.HYP.0000259942.38108.20","volume":"49","author":"M Yamazato","year":"2007","unstructured":"Yamazato M, Yamazato Y, Sun C, Diez-Freire C, Raizada MK (2007) Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats. Hypertension 49(4):926\u2013931. \n                    https:\/\/doi.org\/10.1161\/01.HYP.0000259942.38108.20","journal-title":"Hypertension"},{"issue":"3","key":"2117_CR60","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1210\/en.2011-1764","volume":"153","author":"T Yoshida","year":"2012","unstructured":"Yoshida T, Semprun-Prieto L, Wainford RD, Sukhanov S, Kapusta DR, Delafontaine P (2012) Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus. Endocrinology 153(3):1411\u20131420. \n                    https:\/\/doi.org\/10.1210\/en.2011-1764","journal-title":"Endocrinology"},{"issue":"3","key":"2117_CR61","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1681\/ASN.2008060628","volume":"20","author":"L Zhang","year":"2009","unstructured":"Zhang L, Du J, Hu Z, Han G, Delafontaine P, Garcia G, Mitch WE (2009) IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. J Am Soc Nephrol 20(3):604\u2013612. \n                    https:\/\/doi.org\/10.1681\/ASN.2008060628","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2117_CR62","doi-asserted-by":"publisher","first-page":"H2402","DOI":"10.1152\/ajpheart.00330.2011","volume":"301","author":"H Zheng","year":"2011","unstructured":"Zheng H, Liu X, Patel KP (2011) Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure. Am J Physiol Heart Circ Physiol 301(6):H2402\u2013H2412. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00330.2011","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00424-018-2117-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-018-2117-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-018-2117-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:06:20Z","timestamp":1549843580000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00424-018-2117-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,11]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["2117"],"URL":"https:\/\/doi.org\/10.1007\/s00424-018-2117-0","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,11]]},"assertion":[{"value":"30 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No conflict of interests","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict(s) of interest\/disclosure(s)"}}]}}